Health Care Select Sector SPDR® ETF (XLV)
121.11
-1.69 (-1.38%)
USD |
NYSEARCA |
Sep 30, 16:00
121.05
-0.06 (-0.05%)
After-Hours: 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.10% | 0.08% | 35.90B | 9.650M |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 1.62% | 4.00% | 7.931B | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Prospectus Benchmark Index | |
| S&P Health Care Select Sector TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Michael Feehily | 11.59 yrs |
| Karl Schneider | 7.59 yrs |
| Dwayne Hancock | 5.66 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
1
7.931B
-3.245B
Category Low
7.931B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of September 30, 2022
Performance Versus Category
As of September 30, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of September 30, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| UnitedHealth Group Inc | 10.31% | 505.04 | -0.74% |
| Johnson & Johnson | 9.38% | 163.36 | -0.71% |
| Eli Lilly and Co | 5.66% | 323.35 | -2.02% |
| AbbVie Inc | 5.48% | 134.21 | -5.96% |
| Pfizer Inc | 5.35% | 43.76 | -0.91% |
| Merck & Co Inc | 4.72% | 86.12 | -0.60% |
| Thermo Fisher Scientific Inc | 4.35% | 507.19 | -1.82% |
| Danaher Corp | 3.74% | 258.29 | -1.47% |
| Abbott Laboratories | 3.71% | 96.76 | -1.56% |
| Bristol-Myers Squibb Co | 3.30% | 71.09 | -0.86% |
News
Headline
Wire
Time (ET)
Basic Info
| Investment Strategy | |
| The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Category Index | S&P 1500 Health Care TR |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | SPDR State Street Global Advisors |
| Prospectus Benchmark Index | |
| S&P Health Care Select Sector TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Michael Feehily | 11.59 yrs |
| Karl Schneider | 7.59 yrs |
| Dwayne Hancock | 5.66 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (9-30-22) | 1.62% |
| 30-Day SEC Yield (9-28-22) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 20.30 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of September 28, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 12/16/1998 |
| Last Annual Report Date | 9/30/2021 |
| Last Prospectus Date | 1/31/2022 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan |
|
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)